As featured on Enterprise Ireland, The Irish Advantage
Automation, artificial intelligence, augmented reality and robotics are among the tools manufacturers can deploy to benefit from radical digital transformation.
As the world awaits a Covid-19 vaccine, the cold truth is that finding an effective vaccine is only the first step. Even if one is approved for use, however, a distinct manufacturing and supply chain challenge lies ahead.
Crest Solutions are an approved vendor who supply 1000's of different critical components to the life sciences industry. We are a key partner to a significant number of well-established suppliers across the globe and we have the relationships and knowledge to provide you with the critical components you need.
Trusted Supplier Partners
Cognex Corporation – Crest Solutions are a platinum level PSI for Cognex which means our customers will get extended warrantees on certain Cognex Hardware ordered through Crest Solutions.
Antares Vision and many others.
Crest Solutions, is proud to announce that it is entering into a new era, announcing a new company structure under the name CXV Global Ltd. This agreement will now bring together three long-time partner companies (Crest Solutions, Xyntek and VistaLink) under the umbrella name of CXV Global to create a single source solution globally.
Engineering services firm Crest Solutions announces 80 new jobs in 2019 by securing contracts with global Life Sciences manufacturers.
Having successfully competed in the UK regional and national rounds in a series of robotic challenges the school scooped the Teamwork Champion and Design Award, which means Technogear have automatically qualified for the World Championships in Louisville, Kentucky later this month.
For over 20 years, Crest Solutions has helped our customers deliver regulatory compliance and guarantee quality, by providing them bespoke machine vision and serialisation solutions.
Effective in Europe from February 2019, EU directive 2011/62/EU, also referred to as EU FMD, aims to reduce counterfeiting of prescription drugs by tracking and tracing the passage of drugs through the entire supply chain.
Under the Directive, all new packs of prescription medicines placed on the market in Europe from February 2019 onwards will have to bear two safety features: a verifiable unique identifier (serialised code) and an anti-tamper device.
However, Serialisation and the systems required to carry it out present significant business benefits, past achieving compliance.
To recap, EU directive 2011/62/EU or EU FMD aims to reduce counterfeiting of prescription drugs by tracking and tracing the passage of drugs through the entire supply chain.
With one year to go for pharmaceutical manufacturers, packaging sites and Marketing Authorisation Holders (MAHs) to achieve compliance with the Falsified Medicines Directive, the team in Crest Solutions have put together this guide to help you meet the deadline.